The NP is evaluating a patient with type 2 diabetes and an A1C that is 7.5% after pharmacotherapy with metformin plus a
Posted: Tue Jul 05, 2022 8:44 am
The NP is evaluating a patient with type 2 diabetes and an A1Cthat is 7.5% after pharmacotherapy with metformin plus asulfonylurea. The patient still has hyperglycemic symptoms.Providers should consider which drug class next?
a. exercise program
b. insulin lantus
c. thiazolidinediones
d. glimepiride
a. exercise program
b. insulin lantus
c. thiazolidinediones
d. glimepiride